Protein science and the future of biotherapeutics
The study of proteins is transforming our understanding of human biology and disease, enabling breakthroughs in diagnostics, drug development, and advanced therapies. In this article, Mathias Uhlén, Professor of Microbiology ...
Podcast with investor Ted Fjällman
NorthX Biologics’ investor and CEO of Flerie, Ted Fjällman made a guest appearance in a recent episode of Värdeskaparna, a podcast taking the audience behind the scenes in the private ...
Q podden with CEO Janet Hoogstraate
Janet Hoogstraate, the CEO of NorthX Biologics, recently appeared in an episode of Q-podden, a podcast on manufacturing, quality and corporate culture in life science. Janet discusses the latest trends and ...
Ensuring every child is vaccinated
On behalf of the Swedish Ministry for Foreign Affairs and Gavi, the Global Vaccine Alliance, NorthX Biologics’ CEO Janet Hoogstraate participated in an important roundtable on “Leveraging Technology and Innovation to Ensure Every ...
The rise of the CDMO era – an investor’s perspective
Based on a presentation given by Thomas Eldered at the PharmaOutsourcing event, Stockholm, Sweden, December 2024. From vertical integration to decentralization The pharmaceutical industry has undergone a seismic shift over ...
Q podden with CQO Thomas Beck
Thomas Beck, the Chief Quality Officer (CQO) at NorthX Biologics, was recently featured in an episode of Q podden, a podcast on manufacturing, quality and corporate culture in life science. In ...
Navigating the complexities of microbial and mammalian manufacturing
With a rich historical legacy and decades of expertise at its two sites, NorthX Biologics has long mastered the complexities of microbial and mammalian manufacturing. By offering capabilities and differentiating ...
Navigating Novo Nordisk’s acquisition of Catalent
In this episode of the Molecule to Market podcast, NorthX Biologics CEO Janet Hoogstraate was invited to discuss the implications of integrating Catalent’s capabilities into Novo Nordisk’s operations and what ...
Advancing the science of technical and therapeutic proteins
NorthX Biologics is at the forefront of technical and therapeutic protein development, playing a critical role in supporting the production of advanced therapies. With over three decades of expertise, NorthX ...